Send us a text Clinical Trials are the Stepping Stones for the progress we have made over the years in the treatment of cancer. We talk to Dr Mohini Varughese who is heavily involved in clinical trials in urology and passionate about the delivery of clinical trials across oncology. We discuss: 🎙️Phase 1,2 &3 trials 💊The benefits for patients 💉The benefits for clinical teams

Send us a text Join us as we return for Part 2 of our conversation with lead medical advisor to MacMillan - Dr Anthony Cunliffe. Anthony is also a practising GP with ideas on how we can work better together - starting with how we keep our patients and GP teams up to date with our oncology letters. We talk about Performance status and why it so important to us in oncology and also how we can make life easier for people to understand our letters without extra work. The oncology letters from cli...

Send us a text How we communicate is so important in all aspects of medicine. In this special 2 part episode we look at demystifying the Language of Oncology. Our letters go to GPs and patients and we speak to Dr Anthony Cunliffe who is the medical lead for Macmillan Cancer Support and a practising GP. If you are GP or acute medic who treats cancer patients or a patient with access to your letters this is a MUST LISTEN. Also those of us oncologists wanting to make our letters useful for GP te...

Send us a text Join us for an episode looking at the role of radiotherapy in cancer treatment. We discuss the principles of radiotherapy with Dr Grant Stewart who has 20 years experience with radiotherapy treatments. This is a great episode for anyone wanting to understand the principles of radiotherapy. IF you are a patient wanting to understand your treatment or a doctor or nurse wanting to know more about radiotherapy please check this out!

Send us a text We are back again discussing stereotactic ablative body radiotherapy (SABR) with Dr Harshani Green from the Royal Marsden Hospital. Join us if : - You want to hear about the evidence from the FASTRACK II trial using renal SABR - You are a centre thinking about setting up renal SABR - You want to hear about the challenges of comparing renal SABR with surgery Will radiotherapy be able to replace cytoreductive nephrectomy in metastatic renal carcinoma? We discuss this and more (pl...

Send us a text Join us for Part 1 of our 2 part Simply Oncology podcast with Dr Harshani Green on Stereotactic Ablative Body Radiotherapy (SABR) in Renal Cell Carcinoma. We discuss the role of high precision radiotherapy treating renal cell carcinoma in those patients where an operation may not be possible. - We discuss the excellent control rates - What size of tumour can we treat? - Will we ever be able to compare Surgery versus SABR for primary renal cell carcinoma cancers?

Send us a text Surgery in Bladder Cancer Bumper episode! We talk to Professor Jim Catto about surgery in Bladder Cancer. 🎙️we discuss the GUSTO trial stratifying bladder cancer therapy by molecular subtype 🎙️we look at quality of life and #cystectomy🎙️we look at surgical outcomes from NIAGARA 🎙️we look at peri-operative trials A bumper Bladder Cancer issue

Send us a text We welcome back Professor Tom Crosby for another episode on oesophageal cancer. In the previous episode we focus on the diagnostic pathway. In this episode we look at option in the metastatic and advanced setting.

Send us a text Join us this week as we hear Professor Tom Crosby share his insights into Oesophageal Cancer. Few people have been so highly regarded or associated with a cancer type like Tom Crosby and Oesophago-Gastric cancer. He has set up and run crucial trials, championed equity

Send us a text Join us for this weeks episode where we discuss the role of PSMA PET scanning in prostate cancer with Dr Amar Challapalli. PSMA PET scanning in prostate cancer has been a game changer in both diagnosis and treatment. We explore its role in the post-prostatectomy space. We look at how PSMA Lutetium offers a new treatment option in prostate cancer.

Send us a text Join us as we return with another special episode with Professor Alison Birtle. This time we discuss Upper Tract Urothelial (or ureteric) Cancer. Alison is an internationally recognised expert in this area and was lead on the POUT adjuvant chemotherapy in ureteric cancer trial. She describes it as the non-identical twin to bladder urothelial cancer and we discuss the different approaches to this rare cancer. Described as 'The Queen of Upper Tract Urothelial Cancer' she sh...

Send us a text 🚨May is Bladder Cancer Awareness Month 🎙️What better way to mark this than a Simply Oncology Podcast - Bladder Cancer episode with the irrepressible Professor Alison Birtle. Alison is an internationally recognised expert in bladder and prostate cancer - and is a Simply Oncology Friend of the Show. 🎙️We discuss the recent peri-operative trials such as NIAGARA 🎙️What do surgical adjuvant and neoadjuvant trails now mean for the bladder cancer pathway?

Send us a text 🤔Do you know your Cancer of Unknown Primary from your Malignancy of Unknown Origin. 🤔Do you think World CUP Alliance is a football tournament? Cancer of unknown primary is the 6th most common cause of cancer death in the UK 🎙️Find out with Dr Natalie Cook from The Christie Hospital who is a UK expert in CUP.

Send us a text Part 2 of our discussion on bladder cancer with Professor Rob Jones. We have new drug classes in Bladder cancer !! We look at Erdafitinib which is coming in the post Immunotherapy space to NHS England. We also look ahead to Antibody Drug Conjugates - in particular Enfortumab Vedotin - with EV 302 trial results and what access to this means for the UK bladder community. These are exciting times and we discuss potential side effects of these classes of drugs and how we inte...

Send us a text The Royal College of Radiologists celebrates 50 years of Royal Charter this year!!! Join us as we explore 50 years of the RCR Royal Charter with the President - Dr Katharine Halliday and Vice President - Dr Tom Roques. We look at the achievements of the Royal College of Radiologists have made over the years and look to the future of cancer care at the RCR. We hear how the RCR is our voice as a community of Radiologists and Oncologists. It guides our learning and sets the standa...

Send us a text Join us for this Simply Oncology is Back in Bladder Cancer with the amazing Prof Rob Jones. Part 1 of 2 on a free ranging overview of metastatic bladder cancer treatment in the UK. Cisplatin vs Carboplatin Role of IO 2nd line chemo?

Send us a text Join us for this episode where we explore Head and Neck cancers and their treatment. This is a group of cancers from the mouth to the vocal cords and make up the 8th most common group of cancers in the UK. Almost 13000 cases happen each year in the UK. We discuss the major role that radiotherapy plays and the process and side effects. Teamwork is a major component of Head and Neck cancer therapy. We also discuss how immunotherapy has a role in advanced Head & Neck cancer. A...

Send us a text Welcome back for our 2nd part of our radiotherapy update on breast cancer. We finish our discussion with Professor Mark Beresford who is Chair of the UK Breast Group. We discuss the timing of radiotherapy around breast reconstruction. We look at situations where we treat other areas such and above the collar bone (supraclavicular) or central area (internal mammary) areas. We examine when radiotherapy may be offered after mastectomy. We also look at when we may be able to avoid ...

Send us a text Join us for the first part of this 2 part masterclass in breast radiotherapy. Breast radiotherapy is a major component of breast cancer treatment. It forms a large part of all radiotherapy delivered across cancer centres. After removal of a breast tumour radiotherapy is offered to reduce the chance of local relapse of the cancer. We talk to Professor Mark Beresford who is chair of the UK Breast Group about how breast radiotherapy has gone from 5 weeks of treatment to 1 week. We...

Send us a text Join us for the 2nd part of our discussion with Dr Olubukola (Bookie) Ayodele on health inequities in cancer care. We look at potential steps to promote health equity. Bookie introduces the concept of 'Cultural Competency' in helping health professionals discuss the very challenging topic that is cancer. We hear how biological difference in blood results can play role in excluding back patients from certain chemotherapy trials. We think about the stepwise change and education n...